🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05166954
Recruiting Observational

Effect of Bariatric Surgery on Cardiac Function in Patients With Hypertension

NCT05166954 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Friendship Hospital
Phase
Observational
Started
2018-08-01
Last updated
2025-02-13

Condition(s) studied

Bariatric SurgeryHypertension

Investigational drug(s) / intervention(s)

LSGRYGB

LSG: Laparoscopic sleeve gastrectomy (LSG) together with medical treatment aiming the control of cardiovascular risks including hypertension, diabetes mellitus or dyslipidemia.

RYGB: Roux-en-Y gastric bypass (LRYGB) together with medical treatment aiming the control of cardiovascular risks including hypertension, diabetes mellitus or dyslipidemia.

Study summary

The purpose of this study is to investigate the effect of bariatric surgery on cardiac function assessed by echocardiography in patients with hypertension.

Eligibility

Sex
ALL
Min age
17 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * 18-70 years old * BMI\>24kg/m2 * Bariatric surgery patients of Beijing Friendship Hospital * History of hypertension and treated with ≥2 antihypertensive drugs for more than 4 weeks * No major barriers to provide written consent Exclusion Criteria: * Secondary hypertension, except because of sleep apnea * cardiovascular disease (myocardial infarction, heart failure, stroke or coronary revascularization) within 6 months * Severe concomitant diseases (autoimmune disease, malignancy, late stage of liver diseases, respiratory diseases and digestive diseases) * Unable to understand or comply with the study procedures

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing Friendship Hospital, Capital Medical University Beijing Beijing Municipality Recruiting

More Beijing Friendship Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05166954 on ClinicalTrials.gov ↗ ← All trials in China